Children and adolescents in low- and middle-income countries living with HIV showed a reduced viral load after treatment with ...

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to pre-exposure prophylaxis (PrEP), based on data presented at ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

The philanthropic arm of a major pharmaceutical company gave several Dallas-based nonprofits hundreds of thousands of dollars ...

Nearly 20 states are moving to restrict assistance programs that help people afford HIV medications and treatment.

A growing number of states are rolling back financial help for HIV medications, according to a recent analysis.

The Trump administration has severely damaged a program credited with saving 26 million lives since its inception in 2003.

Residency-trained clinical pharmacists delivered tobacco use disorder treatment within HIV clinics over 10 visits across 24 weeks, supporting feasibility of embedding cessation services in routine HIV ...

There has been an alarming escalation of violence in the Kordofan region where fighting has killed and injured civilians, destroyed homes, hospitals and other civilian infrastructure.

South Africa is in discussions with Gilead Sciences (GILD) to reach an agreement that allows the production of the U.S. biotech’s new twice-yearly HIV therapy, lenacapavir, in the country, home to the ...